Related Experiment Videos
Chimerism and xenotransplantation. New concepts
T E Starzl1, A S Rao, N Murase
1Thomas E. Starzl Transplantation Institute, Pittsburgh, Pennsylvania, USA.
The Surgical Clinics of North America
|March 12, 1999
Summary
Altering transgenic xenograft epitopes can improve immune acceptance, potentially enabling clinical xenotransplantation. Further research is needed on complement regulatory genes for successful organ transplantation.
Area of Science:
- Transplantation immunology
- Xenotransplantation research
- Genetic engineering in organ donation
Background:
- Immune response to antigens is key in transplantation and infection.
- Transgenic xenografts require "humanized" epitopes to avoid innate immunity.
- Species-specific complement reactions pose a challenge in xenotransplantation.
Purpose of the Study:
- To explore the potential of xenotransplantation as a viable organ replacement strategy.
- To address the immunological barriers in xenotransplantation, including epitope modification and complement system compatibility.
- To evaluate the feasibility of using genetically modified animal donors for human transplantation.
Main Methods:
- Analysis of immune response mechanisms in xenotransplantation.
- Investigating the role of "humanized" antigenic epitopes in graft acceptance.
- Examining the necessity of human complement regulatory genes in animal donors.
Main Results:
- Altering xenograft epitopes may allow engraftment mechanisms similar to allograft acceptance.
- The liver's role in complement production suggests variable needs for regulatory transgenes.
- Xenografts can integrate physiologically, but metabolic incompatibilities may cause disease.
Conclusions:
- Clinical xenotransplantation, including from discordant donors like pigs, may be achievable with current insights.
- Overcoming xenogeneic and allogeneic barriers is crucial for advancing transplantation.
- Advancements in transgenic technology bring clinical xenotransplantation closer to reality.